Please login to the form below

Not currently logged in
Email:
Password:

Ramprasad Reddy to chair Aurobindo’s US business

Will also step down from position as full-time director

P V Ramprasad Reddy, who resigned as executive chair of the board of Indian firm Aurobindo in June, 2012, has been appointed chair of its US subsidiary, Aurobindo Pharma USA.

The decision was approved by Aurobindo's board of directors in a meeting last week, although the proposal is still subject to further approval from shareholders, with an extraordinary general meeting scheduled for September 27, 2012 to confirm the appointment.

If approved, Ramprasad Reddy will assume his new position on December 1, 2012.

In addition, Aurobindo's board also approved that Ramprasad Reddy relinquish his executive responsibilities as full-time director of the company, although he will continue as non-exectuive director.

Ramprasad Reddy also has roles at several other Aurobindo subsidiaries, which include serving as director of APL Pharma Thai Limited, Aurobindo (Datong) Bio-Pharma and Aurobindo Tongling (Datong) Pharmaceutical.

In 2008, World Pharmaceutical Frontiers named Ramprasad Reddy as one of the 35 most influential people in the pharmaceutical industry.

29th August 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CAN advertising

Brief us and you’ll soon see we really CAN do it all. We’re different to other agencies. You’ll get expert...

Latest intelligence

Harnessing complexity
Companion diagnostics in oncology...
"Not Another Boring Survey?"
Winning over HCPs… How to Increase Participant Engagement in Healthcare Market Research...
What pharma needs to know about genomic data in 2016
Consultant David Cooney from Blue Latitude Health talks us through what this progress in genomics means for pharma in 2016....

Infographics